J Gynecol Oncol.
2019 Jul;30(4):e79. 10.3802/jgo.2019.30.e79.
The current situation of the levonorgestrel intrauterine system (LNG-IUS) in conservative treatment for patients with early-stage endometrial cancer and atypical hyperplasia
- Affiliations
-
- 1Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China. cxjlhjj@163.com
- 2Shanghai Key Laboratory of Female Reproductive Endocrine Related Diseases, Shanghai, China.
- KMID: 2450244
- DOI: http://doi.org/10.3802/jgo.2019.30.e79
Abstract
- No abstract available.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Clinical applications of levonorgestrel-releasing intrauterine system to gynecologic diseases
- The effectiveness of levonorgestrel releasing intrauterine system in the treatment of endometrial hyperplasia in Korean women
- Clinical applications of levonorgestrel-releasing intrauterine system (LNG-IUS: Mirena(R)) in gynecologic diseases
- Medically unfit women with early-stage endometrial cancer treated with the levonorgestrel intrauterine system
- Therapeutic efficacy of Mirena in gynecologic disease
